Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bordeaux
Clinical trial register · France

Clinical Trials in Bordeaux, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 46 Marseille 37 Toulouse 32 Bordeaux 29 Lille 23
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Bordeaux126 AstraZeneca62 Assistance Publique - Hôpitaux de Paris44 UNICANCER40 Novartis Pharmaceuticals35 Clear sponsor filter
Site location
Paris46 Marseille37 Toulouse32 Bordeaux29 Lille23
All 72 locations
Target enrolment
to

Trials with a site in Bordeaux

29 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Bordeaux, Nantes, Lyon
2026-07-06
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
55
Bordeaux
2026-02-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Strasbourg, Brest, Caen, Chambray-lès-Tours, Bordeaux, Toulouse, Paris
2026-01-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Bordeaux, Toulouse, Nantes, Lyon, Bobigny, Paris
2025-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Bordeaux, Suresnes, Montpellier, La Tronche, Nancy, Angers, Bayonne, Pierre-Bénite
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Bordeaux, Lille, Saint-Herblain, Bayonne, Pierre-Bénite
2025-07-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Lyon, Bordeaux, Toulon, Paris
2025-06-09
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Bordeaux, Marseille, Nantes, Lyon, Paris
2025-05-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Marseille, Caen, Plérin, Bordeaux, Toulouse, Saint-Cloud, Saint-Herblain, Lyon
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Lille, Bordeaux, Pierre-Bénite, Caen, Plérin, Toulouse, Chambray-lès-Tours, Paris
2025-04-09
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Dijon, Bordeaux, Rouen, Suresnes, Paris
2025-03-11
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Bordeaux, Lyon, Nantes, Marseille, Villejuif
2024-08-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bordeaux, Lyon Cedex08, Clermont-Ferrand, Strasbourg, Marseille, Plérin, Besançon, Toulouse
2024-07-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Bordeaux, Strasbourg, Paris, Villejuif
2024-05-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Bordeaux, Lyon, Caen, Toulouse, Lille, Rennes, Poitiers, Paris
2024-05-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Bordeaux, Lyon Cedex08, Strasbourg, Brest, Quint-Fonsegrives, Lille, Suresnes, Clermont-Ferrand
2023-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bordeaux, Lyon Cedex08, Chambray-lès-Tours, Plérin, Besançon, Toulouse, Lille, Montpellier
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Bordeaux, Lyon Cedex08, Rouen, Paris
2023-11-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Nice, Marseille, Dijon, Besançon, Bordeaux, Rennes, Lille, Pierre-Bénite
2023-07-19
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
390
Bordeaux, Dijon, Toulouse, Pierre-Bénite, Paris
2023-06-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Nice, Dijon, Bordeaux, Toulouse, Rouen, Montpellier, Nantes, Tourcoing
2021-09-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Reims, Nice, Strasbourg, Bordeaux, Toulouse, Limoges, Saint-Herblain, Angers
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Vandœuvre-lès-Nancy, Nice, Caen, Plérin, Besançon, Bordeaux, Toulouse, Montpellier
2021-01-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Saint-Quentin, Bordeaux, Marseille, Grenoble, Saint-Herblain, Angers, Bobigny, Toulon
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Strasbourg, Bordeaux, Caen, Besançon, Nîmes, Vandœuvre-lès-Nancy, Pierre-Bénite, Villejuif
2020-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Marseille, Dijon, Caen, Besançon, Nîmes, Bordeaux, Toulouse, Montpellier
2019-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Poitiers, Nice, Strasbourg, Dijon, Bordeaux, Villejuif
2018-12-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Montpellier, Rennes, Angers
2018-09-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Lyon, Marseille, Bordeaux, Lille, Villejuif, Paris
2018-04-09
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/bordeaux

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Bordeaux that also match the filters currently applied.

How many clinical trials are recruiting in Bordeaux?

13 of the 29 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bordeaux), 29 studies
PhaseStudiesRecruitingShare
Phase 317558.6%
Phase 1/27624.1%
Phase 24113.8%
Phase 2/3113.4%

Most active sponsors

Lead sponsors with the most studies (Bordeaux)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2913
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.